http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8119668-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_031d9d639f018905071b73bf75787946 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b42b4d34025aa4651d0b4e9ce5bcfb99 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4172 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402 |
| filingDate | 2006-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e24a0132184ae978aa4e8e95baa7e45c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98be11a2b29173c7122e16ad20da1cfa |
| publicationDate | 2012-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8119668-B2 |
| titleOfInvention | Treatment methods employing histamine H3 receptor antagonists, including betahistine |
| abstract | Methods of treating depression, binge eating disorder, narcolepsy, excessive daytime sleepiness, substance use disorders, and Prader Willi syndrome, disorders characterized at least in part by hypocortisolemia and decreased activity of the hypothalamic-pituitary-adrenal (HPA) axis, and disorders related to disturbances in circadian rhythm, comprising the step of administering an effective amount of a histamine type 3 (Bb) receptor antagonist, such as betahistine or its pharmaceutically acceptable salts, or its metabolites to an individual. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10456386-B2 |
| priorityDate | 2005-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 412.